B-Venture 2020 – Bilbao
Cancerappy had the opportunity to present its project as it was one of the 24 startups selected to present in this year’s edition of B-Venture2020 that was held in October in Bilbao.
Cancerappy had the opportunity to present its project as it was one of the 24 startups selected to present in this year’s edition of B-Venture2020 that was held in October in Bilbao.
CancerAppy was one of the 24 projects selected to exhibit at the B-venture 2020 Bilbao.
AI + Drug Interaction / Personalized Medicine
Meet Sarah.
She’s a scientist who does research on medications that treat cancer. Now Sarah’s a busy woman, so she doesn’t have the 21 hours a day it would take to read and process all the new information that comes out about cancer everyday.
But luckily for Sarah, we’ve got a solution for that: CANCERAPPY.
Cancerappy analyzes, organizes, and synthesizes all the information a cancer researcher needs, providing a holistic vision and saving valuable time and resources.
Cancerappy works because we created our own algorithm using artificial intelligence and these are things it gives us:
-Health Care Solutions
-Best Personalized Treatment
-Optimal drug development
Cancerappy provides unique value through the precise metrics it offers through big data and artificial intelligence which helps oncology professionals like Sarah make better decisions, save time, and increase the quality of care for any cancer patient.
CancerAppy raised a pre-seed round of € 120K.
In the middle of the Covid pandemic and with the lockdown active, the CancerAppy team, led by its CEO Luis Martín, closed the negotiations for a pre-seed round with a group of local investors.
This allows us to move faster to meet the milestones set for this year 2020.